ARPANSA is currently seeking nominations for members of the Radiation Health and Safety Advisory Council. The Minister-appointed Council advise the CEO on emerging issues and matters of major public concern relating to radiation protection and nuclear safety.
In the first study of its kind in Australia, ARPANSA produced a report on radiation in foods that make up a typical Australian diet. The results showed levels are very low and do not present any health concerns.
Part of ARPANSA’s role is the regulation of all Commonwealth entities that use radiation. Regulation ensures compliance with the Australian Radiation Protection and Nuclear Safety Act 1998 and associated Regulations (2018) and is supported by a series of regulatory guides.
In December 2018, the British Medical Journal Open published a scientific study led by ARPANSA investigating the relationship between brain cancer and mobile phone use.
Since the publication of the original study, the authors have conducted further analysis of additional age groups.
We’re pleased to announce that the newest location in our ultraviolet (UV) radiation monitoring network is now online. Emerald is the fourth location in Queensland to join our network of real-time UV data.
ARPANSA collates and publishes an annual report on radiation incidents in Australia. This report is produced with input from various radiation regulators around the country, based on incidents submitted to them and any subsequent investigations they carry out.
In Australia, skin cancer accounts for around 80% of all newly diagnosed cancers each year and UV radiation from the sun is one of the leading causes of skin cancer. With high UV radiation year-round in many parts of Australia, people who regularly work outside face a higher risk of developing cancer from sun exposure.
Dr Gillian Hirth, deputy CEO and Head of ARPANSA's Radiation Health Services Branch, has been elected as Chair of the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) for the 66th and 67th sessions
On Friday 21 June 2019, ARPANSA was notified of a radiation contamination event at the Australian Nuclear Science and Technology Organisation (ANSTO) Nuclear Medicine (ANM) production facility in Lucas Heights, New South Wales.
Recently, ARPANSA co-authored a new study which found that modern airline pilots registered in Australia, appear not to be at higher risk of developing invasive melanoma than the rest of the population.